Nothing Special   »   [go: up one dir, main page]

CY1105025T1 - LEPTIN ANALYSIS BASED ON ANG-2 EXPRESSION DETECTION - Google Patents

LEPTIN ANALYSIS BASED ON ANG-2 EXPRESSION DETECTION

Info

Publication number
CY1105025T1
CY1105025T1 CY20061100582T CY061100582T CY1105025T1 CY 1105025 T1 CY1105025 T1 CY 1105025T1 CY 20061100582 T CY20061100582 T CY 20061100582T CY 061100582 T CY061100582 T CY 061100582T CY 1105025 T1 CY1105025 T1 CY 1105025T1
Authority
CY
Cyprus
Prior art keywords
ang
analysis based
expression detection
leptin
leptin analysis
Prior art date
Application number
CY20061100582T
Other languages
Greek (el)
Inventor
Menachem Rubinstein
Batya Cohen
Original Assignee
Yeda Research And Development Company, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research And Development Company, Ltd. filed Critical Yeda Research And Development Company, Ltd.
Publication of CY1105025T1 publication Critical patent/CY1105025T1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

H εφεύρεση παρέχει μία μέθοδο για να καθορίζει την παρουσία λεπτίνης σε ένα δείγμα.The invention provides a method to determine the presence of leptin in a sample.

CY20061100582T 1999-10-11 2006-05-04 LEPTIN ANALYSIS BASED ON ANG-2 EXPRESSION DETECTION CY1105025T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL13231399A IL132313A0 (en) 1999-10-11 1999-10-11 Leptin assay
PCT/IL2000/000621 WO2001027319A2 (en) 1999-10-10 2000-10-05 Leptin assay based on detecting ang-2 expression

Publications (1)

Publication Number Publication Date
CY1105025T1 true CY1105025T1 (en) 2010-03-03

Family

ID=11073317

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061100582T CY1105025T1 (en) 1999-10-11 2006-05-04 LEPTIN ANALYSIS BASED ON ANG-2 EXPRESSION DETECTION

Country Status (24)

Country Link
US (1) US7247427B1 (en)
EP (1) EP1222467B1 (en)
JP (1) JP2003511057A (en)
KR (1) KR100863580B1 (en)
CN (1) CN1159585C (en)
AR (1) AR025995A1 (en)
AT (1) ATE322017T1 (en)
AU (1) AU778727B2 (en)
BR (1) BR0014626A (en)
CA (1) CA2386365A1 (en)
CY (1) CY1105025T1 (en)
DE (1) DE60027031T2 (en)
DK (1) DK1222467T3 (en)
EA (1) EA004709B1 (en)
EE (1) EE200200189A (en)
ES (1) ES2256045T3 (en)
HK (1) HK1048514B (en)
IL (2) IL132313A0 (en)
NO (1) NO20021604L (en)
PT (1) PT1222467E (en)
SI (1) SI1222467T1 (en)
UA (1) UA77153C2 (en)
WO (1) WO2001027319A2 (en)
ZA (1) ZA200202155B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2372364A1 (en) * 2010-03-31 2011-10-05 Medizinische Hochschule Hannover Biomarker for pulmonary hypertension
CN103597071A (en) 2011-01-07 2014-02-19 埃尔舍利克斯治疗公司 Chemosensory receptor ligand-based therapies
US9795792B2 (en) 2011-02-25 2017-10-24 Medtronic, Inc. Emergency mode switching for non-pacing modes
CN102221615A (en) * 2011-03-31 2011-10-19 广州华灿医药科技有限公司 Double-antibody sandwich ELISA method based on Angiogenin detection
KR102231554B1 (en) 2012-01-06 2021-03-23 앤지 파마 유에스 엘엘씨 Compositions and methods for treating metabolic disorders
KR102035879B1 (en) 2012-01-06 2019-10-23 엘셀릭스 테라퓨틱스 인코포레이티드 Biguanide compositions and methods of treating metabolic disorders
WO2013158928A2 (en) 2012-04-18 2013-10-24 Elcelyx Therapeutics, Inc. Chemosensory receptor ligand-based therapies
CA2878625A1 (en) 2012-07-11 2014-01-16 Elcelyx Therapeutics, Inc. Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
CN102901823A (en) * 2012-10-26 2013-01-30 安徽安科生物工程（集团）股份有限公司 Leptin detection kit
MX2020011594A (en) 2013-01-05 2022-01-13 Anji Pharma Us Llc Delayed-release composition comprising biguanide.
CN104459105B (en) * 2014-12-05 2016-03-09 重庆中元生物技术有限公司 A kind of latex enhancing immune detecting LP is than turbid kit and preparation method thereof
CN114940717B (en) * 2022-06-30 2024-04-26 武汉海特生物制药股份有限公司 Chimeric receptor, 32D leptin-sensitive cell strain and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997040380A1 (en) 1996-04-22 1997-10-30 Merck & Co., Inc. Leptin assay

Also Published As

Publication number Publication date
NO20021604D0 (en) 2002-04-04
HK1048514A1 (en) 2003-04-04
ZA200202155B (en) 2003-05-28
AR025995A1 (en) 2002-12-26
KR100863580B1 (en) 2008-10-15
DE60027031T2 (en) 2006-08-24
US7247427B1 (en) 2007-07-24
DK1222467T3 (en) 2006-08-07
EA200200435A1 (en) 2002-10-31
IL149021A0 (en) 2002-11-10
AU7814100A (en) 2001-04-23
UA77153C2 (en) 2006-11-15
EA004709B1 (en) 2004-06-24
SI1222467T1 (en) 2006-06-30
EE200200189A (en) 2003-06-16
BR0014626A (en) 2002-06-11
CN1378648A (en) 2002-11-06
PT1222467E (en) 2006-06-30
KR20020048416A (en) 2002-06-22
CN1159585C (en) 2004-07-28
IL132313A0 (en) 2001-03-19
ATE322017T1 (en) 2006-04-15
EP1222467B1 (en) 2006-03-29
WO2001027319A2 (en) 2001-04-19
EP1222467A2 (en) 2002-07-17
HK1048514B (en) 2004-12-31
IL149021A (en) 2007-12-03
CA2386365A1 (en) 2001-04-19
WO2001027319A3 (en) 2001-06-21
ES2256045T3 (en) 2006-07-16
JP2003511057A (en) 2003-03-25
NO20021604L (en) 2002-04-04
DE60027031D1 (en) 2006-05-18
AU778727B2 (en) 2004-12-16

Similar Documents

Publication Publication Date Title
CY1105025T1 (en) LEPTIN ANALYSIS BASED ON ANG-2 EXPRESSION DETECTION
DE60128279D1 (en) Optical sensor for the detection of several analytes
DK1199569T3 (en) Sample analysis system
DK0988534T3 (en) Electronic methods and apparatus for detecting analytes
ATE232559T1 (en) METHOD FOR SIGNAL AMPLIFICATION
FI20011877A (en) Method and biosensor for analysis
DK1137943T3 (en) Method for detection of cancer and reagents
DE69735445D1 (en) NON-VOLATILE, NON-VOLATILE MOLECULES FOR MASS MARKING
DK1371984T3 (en) Chromatographic assay device and method for detecting the presence of an analyte in a whole blood sample
DE60038403D1 (en) Sampling fluorescence detection device for multiple samples.
AU2002367206A8 (en) Analysis system for determining an analyte concentration, taking into consideration sample- and analyte-independent light-intensity changes
HUP0002923A2 (en) Method and apparatus for rapid analysis of analytes in biological samples
NO20031116L (en) Test strips for detecting the presence of a reduced cofactor in a sample and methods for using them
DE69930404D1 (en) METHOD FOR THE DETECTION OF ANALYTES
ATE466659T1 (en) SAMPLING SYSTEM WITH PHOSPHATASE INHIBITOR
DE69930185D1 (en) Sampling fluorescence detection device
NO20003515D0 (en) Procedure for identifying validated measurement and analysis combinations
DE69736313D1 (en) Device for gas concentration detection
ATE285581T1 (en) ASSAY PROCEDURE
DE59713051D1 (en) sample
MX9706437A (en) Process and compounds for use in detecting analytes by measurement of residual magnetism, and the use of the said compounds.
DE59804890D1 (en) DEVICE FOR ANALYZING GASEOUS SAMPLES
CY1106705T1 (en) TEST FOR MEASUREMENT OF ALL-TRANSCOBALAMIN AND FOLATE
DK1190245T3 (en) Allergen detection
DE69618904D1 (en) sample analysis